Abionyx
Presence
Abionyx is one of the...
Abionyx is a company listed under the stock ticker ABNX (FR).
Executives
View the org chart displaying its 9 main executives
Most searched biographies at Abionyx
- Cyrille Tupin, Chief Executive Officer and Director
- Emmanuel Huynh, Chairman of the Board
- Karen Noel, Director
Popular executive movements at Abionyx
- Rob Scott has joined the company as Chief Medical Officer and Head of R&D (posted on January 9 2024).
Create your alert
to follow the executive moves at Abionyx.
Biotechnology
Abionyx has 2,297 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Actuate Therapeutics has just announced a $50 Million fundraising (posted on May 29 2024).
- Grey Wolf Therapeutics has just announced a $50 Million fundraising (posted on May 25 2024).
- AbbVie has acquired Landos Biopharma (posted on May 25 2024).
Popular contacts in Biotechnology
News
Press releases by Abionyx
- CERENIS - THERAPEUTICS - Positive results from the CER-209 Phase I Single Dose Tolerance study for NAFLD and NASH
- CERENIS - THERAPEUTICS - Publication of 2016 Registration Document
- CERENIS - THERAPEUTICS - Cash position and update on clinical developments for Q1 2017
Social media about Abionyx
- Abionyx on Wikipedia, Google News & Yahoo Finance
- Abionyx on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Cyrille Tupin 
